Overexpression of the Mcl-1 protein or amplification of the Mcl-1 gene in malignant cells can prevent apoptosis and reduce sensitivity to commonly used anticancer drugs [11], making Mcl-1 a potential drug target for cancer. Here, MCL1 is linked to cancer.